Frontiers in Oncology | Hematologic Malignancies

Mini Review

Published on 11 May 2021

Ocular Toxicity of Belantamab Mafodotin, an Oncological Perspective of Management in Relapsed and Refractory Multiple Myeloma

in Hematologic Malignancies

Ahsan Wahab
Abdul Rafae
Kamran Mushtaq
Adeel Masood
Hamid Ehsan
Maria Khakwani
Aqsa Khan

Frontiers in Oncology

doi 10.3389/fonc.2021.678634

27,349 views
76 citations

Review

Published on 10 May 2021

AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression

in Hematologic Malignancies

Pablo Oppezzo
Marcelo Navarrete
Nicholas Chiorazzi

Frontiers in Oncology

doi 10.3389/fonc.2021.634383

12,832 views
23 citations

Review

Published on 10 May 2021

Immunotherapy in Acute Myeloid Leukemia: Where We Stand

in Hematologic Malignancies

Alessandro Isidori
Claudio Cerchione
Naval Daver
Courtney DiNardo
Guillermo Garcia-Manero
Marina Konopleva
Elias Jabbour
Farhad Ravandi
Tapan Kadia
Adolfo de la Fuente Burguera

Frontiers in Oncology

doi 10.3389/fonc.2021.656218

36,833 views
89 citations

Review

Published on 05 May 2021

The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies

in Hematologic Malignancies

Carolina Simioni
Ilaria Conti
Gabriele Varano
Cinzia Brenna
Eva Costanzi
Luca M. Neri

Frontiers in Oncology

doi 10.3389/fonc.2021.673506

7,886 views
22 citations

Original Research

Published on 04 May 2021

Epigenetic Silencing of Immune-Checkpoint Receptors in Bone Marrow- Infiltrating T Cells in Acute Myeloid Leukemia

in Hematologic Malignancies

Ramin Radpour
Miriam Stucki
Carsten Riether
Adrian F. Ochsenbein

Frontiers in Oncology

doi 10.3389/fonc.2021.663406

6,153 views
23 citations

Review

Published on 03 May 2021

Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia

in Hematologic Malignancies

Noortje van Gils
Fedor Denkers
Linda Smit

Frontiers in Oncology

doi 10.3389/fonc.2021.659253

19,291 views
91 citations

Brief Research Report

Published on 29 Apr 2021

Letermovir Administration to Prevent Cytomegalovirus Reactivation Is the Potential Risk of Chronic Graft-Versus-Host Disease in Patients Who Received Haploidentical Stem-Cell Transplantation With Post-Transplant Cyclophosphamide

in Hematologic Malignancies

Toshiki Terao
Ken-ichi Matsuoka
Kentaro Narita
Takafumi Tsushima
Satoshi Yuyama
Ayumi Kuzume
Rikako Tabata
Daisuke Miura
Masami Takeuchi
Kosei Matsue

Frontiers in Oncology

doi 10.3389/fonc.2021.666774

5,028 views
11 citations

Case Report

Published on 29 Apr 2021

Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report

in Hematologic Malignancies

Ting-Ting Yang
Wei-Hao Chen
Yan-Min Zhao
Hua-Rui Fu
He Huang
Ji-Min Shi

Frontiers in Oncology

doi 10.3389/fonc.2021.672052

4,876 views
14 citations

Original Research

Published on 29 Apr 2021

Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy

in Hematologic Malignancies

Qian Luo
Chunli Yang
Chunxi Fu
Wanchun Wu
Yi Wei
Liqun Zou

Frontiers in Oncology

doi 10.3389/fonc.2021.639644

4,493 views
16 citations

Review

Published on 29 Apr 2021

Clinical and Molecular Properties of Human Immunodeficiency Virus-Related Diffuse Large B-Cell Lymphoma

in Hematologic Malignancies

Pedro S. de Carvalho
Fabio E. Leal
Marcelo A. Soares

Frontiers in Oncology

doi 10.3389/fonc.2021.675353

7,237 views
22 citations

Review

Published on 29 Apr 2021

Relapsed Primary Central Nervous System Lymphoma: Current Advances

in Hematologic Malignancies

Kaiyan Tao
Xuefeng Wang
Xin Tian

Frontiers in Oncology

doi 10.3389/fonc.2021.649789

25,007 views
32 citations

Mini Review

Published on 29 Apr 2021

Taming Cell-to-Cell Heterogeneity in Acute Myeloid Leukaemia With Machine Learning

in Hematologic Malignancies

Yara E. Sánchez-Corrales
Ruben V. C. Pohle
Sergi Castellano
Alice Giustacchini

Frontiers in Oncology

doi 10.3389/fonc.2021.666829

8,319 views
4 citations

Original Research

Published on 28 Apr 2021

Altered T Follicular Helper Cell Subsets and Function in Chronic Lymphocytic Leukemia

in Hematologic Malignancies

Xun Wu
J. Ernesto Fajardo-Despaigne
Christine Zhang
Vishala Neppalli
Versha Banerji
James B. Johnston
Spencer B. Gibson
Aaron J. Marshall

Frontiers in Oncology

doi 10.3389/fonc.2021.674492

6,045 views
27 citations

Case Report

Published on 27 Apr 2021

Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors

in Hematologic Malignancies

Elisa Lucchini
Marco Merlo
Mario Ballerini
Aldostefano Porcari
Gianfranco Sinagra
Lorenzo Pagnan
Marco Rensi
Andrea Romano
Rossana Bussani
Laura Ballotta

Frontiers in Oncology

doi 10.3389/fonc.2021.665736

7,347 views
12 citations

Opinion

Published on 27 Apr 2021

Current Challenges in Hematology: Awareness, Prevention, Equity

in Hematologic Malignancies

Dominic Kaye
Alessandro Isidori

Frontiers in Oncology

doi 10.3389/fonc.2021.653020

6,675 views
5 citations

Systematic Review

Published on 26 Apr 2021

Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review

in Hematologic Malignancies

Yuan Yang
Jiang Ji
Zengwei Tang
Bing Han

Frontiers in Oncology

doi 10.3389/fonc.2021.614965

6,670 views
5 citations

Brief Research Report

Published on 23 Apr 2021

Targeting Bruton Tyrosine Kinase With Zanubrutinib for Treatment of Vitreoretinal Lymphoma: Report of 3 Cases

in Hematologic Malignancies

Liang Wang
Wenxue Guan
Xiaoyan Peng

Frontiers in Oncology

doi 10.3389/fonc.2021.676792

4,883 views
13 citations

Original Research

Published on 21 Apr 2021

The Clinical Accuracy and Risk Stratification in End of Therapy 18F-FDG PET/CT in Burkitt Lymphoma

in Hematologic Malignancies

Yi Wen Mo
Zi Zheng Xiao
Yuan Wei
Xin Ling Li
Xu Zhang
Wei Fan

Frontiers in Oncology

doi 10.3389/fonc.2021.625436

4,169 views
7 citations

Original Research

Published on 21 Apr 2021

Wilms Tumor 1 Mutations Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia

in Hematologic Malignancies

Yin Wang
Wen-Jun Weng
Dun-Hua Zhou
Jian-Pei Fang
Srishti Mishra
Li Chai
Lu-Hong Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.632094

6,508 views
18 citations

Original Research

Published on 20 Apr 2021

c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study

in Hematologic Malignancies

Nathalie Faumont
Oussama Taoui
Davi Collares
Jean-Philippe Jais
Karen Leroy
Léa Prévaud
Fabrice Jardin
Thierry J. Molina
Christiane Copie-Bergman
Barbara Petit

Frontiers in Oncology

doi 10.3389/fonc.2021.638897

8,285 views
19 citations

Original Research

Published on 15 Apr 2021

Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Laurence C. Cheung
Rebecca de Kraa
Joyce Oommen
Grace-Alyssa Chua
Sajla Singh
Anastasia M. Hughes
Emanuela Ferrari
Jette Ford
Sung K. Chiu
Ronald W. Stam

Frontiers in Oncology

doi 10.3389/fonc.2021.631594

6,233 views
20 citations

Editorial

Published on 15 Apr 2021

Editorial: The Biological Landscape of Immunotherapy in AML

in Hematologic Malignancies

Alessandro Isidori
Naval Daver
Antonio Curti

Frontiers in Oncology

doi 10.3389/fonc.2021.671252

3,377 views
8 citations

Case Report

Published on 15 Apr 2021

Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia

in Hematologic Malignancies

Leo Ruhnke
Friedrich Stölzel
Lisa Wagenführ
Heidi Altmann
Uwe Platzbecker
Sylvia Herold
Andreas Rump
Evelin Schröck
Martin Bornhäuser
Johannes Schetelig

Frontiers in Oncology

doi 10.3389/fonc.2021.666014

4,160 views
5 citations

Original Research

Published on 15 Apr 2021

Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study

in Hematologic Malignancies

Fabrizio Cavalca
Rossella Renso
Giovanni Paolo Maria Zambrotta
Carlo Gambacorti-Passerini
Elena Maria Elli

Frontiers in Oncology

doi 10.3389/fonc.2021.668261

3,200 views
2 citations

2,070 articles

articles

Ocular Toxicity of Belantamab Mafodotin, an Oncological Perspective of Management in Relapsed and Refractory Multiple Myeloma

AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression

Immunotherapy in Acute Myeloid Leukemia: Where We Stand

The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies

Epigenetic Silencing of Immune-Checkpoint Receptors in Bone Marrow- Infiltrating T Cells in Acute Myeloid Leukemia

Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia

Letermovir Administration to Prevent Cytomegalovirus Reactivation Is the Potential Risk of Chronic Graft-Versus-Host Disease in Patients Who Received Haploidentical Stem-Cell Transplantation With Post-Transplant Cyclophosphamide

Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report

Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy

Clinical and Molecular Properties of Human Immunodeficiency Virus-Related Diffuse Large B-Cell Lymphoma

Relapsed Primary Central Nervous System Lymphoma: Current Advances

Taming Cell-to-Cell Heterogeneity in Acute Myeloid Leukaemia With Machine Learning

Altered T Follicular Helper Cell Subsets and Function in Chronic Lymphocytic Leukemia

Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors

Current Challenges in Hematology: Awareness, Prevention, Equity

Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review

Targeting Bruton Tyrosine Kinase With Zanubrutinib for Treatment of Vitreoretinal Lymphoma: Report of 3 Cases

The Clinical Accuracy and Risk Stratification in End of Therapy 18F-FDG PET/CT in Burkitt Lymphoma

Wilms Tumor 1 Mutations Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia

c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study

Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia

Editorial: The Biological Landscape of Immunotherapy in AML

Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia

Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study